Report Detail

Pharma & Healthcare Global Bacterial Conjunctivitis Drugs Market Research Report 2019

  • RnM3123031
  • |
  • 14 March, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Conjunctivitis is an inflammation of the conjunctiva - the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis is one of the most commonly observed eye problems across all age groups, generally caused by bacteria such as Staphylococcus aureus, Moraxella lacunata, Haemophilus influenza, and others (e.g. Chlamydia trachomatis, Proteus mirabilis, etc.). 
The development of multi-drug resistant variants, which is resulting in the augmented use of drugs, is expected to boost market growth during the forecast period. Microbes such as Streptococcus or Staphylococcus are responsible for bacterial conjunctivitis. These microbes change themselves chemically to develop resistance to the drugs. Since this resistance develops due to the irrational use of antibiotics, it may lead to severe complications in the body of the patients. Patients are thus expected to take up more medications such as corticosteroids and higher doses of antibiotics for the treatment of such diseases. This augmented use of drugs like corticosteroids and antibiotics for the treatment of bacterial conjunctivitis will propel the prospects for growth in this market.
The growing genericization of antibacterial drugs has impacted the demand for branded drugs significantly. The generic versions of patented formulations, with almost same efficiency as the latter, are easily available at much lower rates in the market. This has increased the sales volume, albeit at the cost of revenues. Many branded ophthalmic drug manufacturers have incurred huge losses due to the generic cannibalization in this market.
The rising prevalence of multi-drug resistant organisms (MDROs), triggered by wide usage of antibiotics, incorrect drug dosage, and inappropriate medications, has created serious challenges for the treatment of infections such as bacterial conjunctivitis. Researchers across the world are working on discovering efficient drugs for these MDROs. However, the non-availability of effective medications in near future is likely to hamper the market’s growth over the coming years.

The global Bacterial Conjunctivitis Drugs market is valued at 430 million US$ in 2018 is expected to reach 320 million US$ by the end of 2025, growing at a CAGR of -3.7% during 2019-2025.
This report focuses on Bacterial Conjunctivitis Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bacterial Conjunctivitis Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Santen Pharmaceutical
Perrigo
Merck
Bayer
Akorn
...

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Fluoroquinolones
Aminoglycosides
Macrolides
Others

Segment by Application
Infective (Viral and Bacterial)
Allergic
Irritant (Chemical)


Table of Contents

    Executive Summary

      1 Bacterial Conjunctivitis Drugs Market Overview

      • 1.1 Product Overview and Scope of Bacterial Conjunctivitis Drugs
      • 1.2 Bacterial Conjunctivitis Drugs Segment by Type
        • 1.2.1 Global Bacterial Conjunctivitis Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Fluoroquinolones
        • 1.2.3 Aminoglycosides
        • 1.2.4 Macrolides
        • 1.2.5 Others
      • 1.3 Bacterial Conjunctivitis Drugs Segment by Application
        • 1.3.1 Bacterial Conjunctivitis Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Infective (Viral and Bacterial)
        • 1.3.3 Allergic
        • 1.3.4 Irritant (Chemical)
      • 1.4 Global Bacterial Conjunctivitis Drugs Market by Region
        • 1.4.1 Global Bacterial Conjunctivitis Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Bacterial Conjunctivitis Drugs Market Size
        • 1.5.1 Global Bacterial Conjunctivitis Drugs Revenue (2014-2025)
        • 1.5.2 Global Bacterial Conjunctivitis Drugs Production (2014-2025)

      2 Global Bacterial Conjunctivitis Drugs Market Competition by Manufacturers

      • 2.1 Global Bacterial Conjunctivitis Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Bacterial Conjunctivitis Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Bacterial Conjunctivitis Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Bacterial Conjunctivitis Drugs Production Sites, Area Served, Product Types
      • 2.5 Bacterial Conjunctivitis Drugs Market Competitive Situation and Trends
        • 2.5.1 Bacterial Conjunctivitis Drugs Market Concentration Rate
        • 2.5.2 Bacterial Conjunctivitis Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Bacterial Conjunctivitis Drugs Production Market Share by Regions

      • 3.1 Global Bacterial Conjunctivitis Drugs Production Market Share by Regions
      • 3.2 Global Bacterial Conjunctivitis Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Bacterial Conjunctivitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Bacterial Conjunctivitis Drugs Production
        • 3.4.1 North America Bacterial Conjunctivitis Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Bacterial Conjunctivitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Bacterial Conjunctivitis Drugs Production
        • 3.5.1 Europe Bacterial Conjunctivitis Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Bacterial Conjunctivitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Bacterial Conjunctivitis Drugs Production (2014-2019)
        • 3.6.1 China Bacterial Conjunctivitis Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Bacterial Conjunctivitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Bacterial Conjunctivitis Drugs Production (2014-2019)
        • 3.7.1 Japan Bacterial Conjunctivitis Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Bacterial Conjunctivitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Bacterial Conjunctivitis Drugs Consumption by Regions

      • 4.1 Global Bacterial Conjunctivitis Drugs Consumption by Regions
      • 4.2 North America Bacterial Conjunctivitis Drugs Consumption (2014-2019)
      • 4.3 Europe Bacterial Conjunctivitis Drugs Consumption (2014-2019)
      • 4.4 China Bacterial Conjunctivitis Drugs Consumption (2014-2019)
      • 4.5 Japan Bacterial Conjunctivitis Drugs Consumption (2014-2019)

      5 Global Bacterial Conjunctivitis Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Bacterial Conjunctivitis Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Bacterial Conjunctivitis Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Bacterial Conjunctivitis Drugs Price by Type (2014-2019)
      • 5.4 Global Bacterial Conjunctivitis Drugs Production Growth by Type (2014-2019)

      6 Global Bacterial Conjunctivitis Drugs Market Analysis by Applications

      • 6.1 Global Bacterial Conjunctivitis Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Bacterial Conjunctivitis Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Bacterial Conjunctivitis Drugs Business

      • 7.1 Santen Pharmaceutical
        • 7.1.1 Santen Pharmaceutical Bacterial Conjunctivitis Drugs Production Sites and Area Served
        • 7.1.2 Bacterial Conjunctivitis Drugs Product Introduction, Application and Specification
        • 7.1.3 Santen Pharmaceutical Bacterial Conjunctivitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Perrigo
        • 7.2.1 Perrigo Bacterial Conjunctivitis Drugs Production Sites and Area Served
        • 7.2.2 Bacterial Conjunctivitis Drugs Product Introduction, Application and Specification
        • 7.2.3 Perrigo Bacterial Conjunctivitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Merck
        • 7.3.1 Merck Bacterial Conjunctivitis Drugs Production Sites and Area Served
        • 7.3.2 Bacterial Conjunctivitis Drugs Product Introduction, Application and Specification
        • 7.3.3 Merck Bacterial Conjunctivitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Bayer
        • 7.4.1 Bayer Bacterial Conjunctivitis Drugs Production Sites and Area Served
        • 7.4.2 Bacterial Conjunctivitis Drugs Product Introduction, Application and Specification
        • 7.4.3 Bayer Bacterial Conjunctivitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Akorn
        • 7.5.1 Akorn Bacterial Conjunctivitis Drugs Production Sites and Area Served
        • 7.5.2 Bacterial Conjunctivitis Drugs Product Introduction, Application and Specification
        • 7.5.3 Akorn Bacterial Conjunctivitis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served

      8 Bacterial Conjunctivitis Drugs Manufacturing Cost Analysis

      • 8.1 Bacterial Conjunctivitis Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Bacterial Conjunctivitis Drugs
      • 8.4 Bacterial Conjunctivitis Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Bacterial Conjunctivitis Drugs Distributors List
      • 9.3 Bacterial Conjunctivitis Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Bacterial Conjunctivitis Drugs Market Forecast

      • 11.1 Global Bacterial Conjunctivitis Drugs Production, Revenue Forecast
        • 11.1.1 Global Bacterial Conjunctivitis Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Bacterial Conjunctivitis Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Bacterial Conjunctivitis Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Bacterial Conjunctivitis Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Bacterial Conjunctivitis Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Bacterial Conjunctivitis Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Bacterial Conjunctivitis Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Bacterial Conjunctivitis Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Bacterial Conjunctivitis Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Bacterial Conjunctivitis Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Bacterial Conjunctivitis Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Bacterial Conjunctivitis Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Bacterial Conjunctivitis Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Bacterial Conjunctivitis Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Bacterial Conjunctivitis Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Bacterial Conjunctivitis Drugs . Industry analysis & Market Report on Bacterial Conjunctivitis Drugs is a syndicated market report, published as Global Bacterial Conjunctivitis Drugs Market Research Report 2019. It is complete Research Study and Industry Analysis of Bacterial Conjunctivitis Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $4,350.00
        $5,800.00
        2,285.20
        3,427.80
        4,570.40
        2,668.00
        4,002.00
        5,336.00
        451,240.00
        676,860.00
        902,480.00
        241,802.00
        362,703.00
        483,604.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report